Opioids combined with antidepressants or antiepileptic drugs for cancer pain : systematic review and meta-analysis

Article indépendant

KANE, Chris M. | MULVEY, Matthew R. | WRIGHT, Sophie | CRAIGS, Cheryl | WRIGHT, Judy M. | BENNETT, Michael I.

Background: Combining antidepressant or antiepileptic drugs with opioids has resulted in increased pain relief when used for neuropathic pain in non-cancer conditions. However, evidence to support their effectiveness in cancer pain is lacking. Aim: To determine if there is additional benefit when opioids are combined with antidepressant or antiepileptic drugs for cancer pain. Design: Systematic review and meta-analysis. Randomised control trials comparing opioid analgesia in combination with antidepressant or antiepileptic drugs versus opioid monotherapy were sought. Data on pain and adverse events were extracted. Data were pooled using DerSimonian–Laird random-effects meta-analyses, and heterogeneity was assessed. Results: Seven randomised controlled trials that randomised 605 patients were included in the review. Patients’ pain was described as neuropathic cancer pain, cancer bone pain and non-specific cancer pain. Four randomised controlled trials were included in the meta-analysis in which opioid in combination with either gabapentin or pregabalin was compared with opioid monotherapy. The pooled standardised mean difference was 0.16 (95% confidence interval, -0.19, 0.51) showing no significant difference in pain relief between the groups. Adverse events were more frequent in the combination arms. Data on amitriptyline, fluvoxamine and phenytoin were inconclusive. Conclusion: Combining opioid analgesia with gabapentinoids did not significantly improve pain relief in patients with tumour-related cancer pain compared with opioid monotherapy. Due to the heterogeneity of patient samples, benefit in patients with definite neuropathic cancer pain cannot be excluded. Clinicians should balance the small likelihood of benefit in patients with tumour-related cancer pain against the increased risk of adverse effects of combination therapy.

http://dx.doi.org/10.1177/0269216317711826

Voir la revue «PALLIATIVE MEDICINE, 32»

Autres numéros de la revue «PALLIATIVE MEDICINE»

Consulter en ligne

Suggestions

Du même auteur

Opioids combined with antidepressants or anti...

Article indépendant | KANE, Chris M. | PALLIATIVE MEDICINE | n°1 | vol.32

Background: Combining antidepressant or antiepileptic drugs with opioids has resulted in increased pain relief when used for neuropathic pain in non-cancer conditions. However, evidence to support their effectiveness in cancer pai...

Duration and determinants of hospice-based sp...

Article | ALLSOP, Matthew J. | PALLIATIVE MEDICINE | n°8 | vol.32

BACKGROUND: Understanding service provision for patients with advanced disease is a research priority, with a need to identify barriers that limit widespread integration of palliative care. AIM: To identify patient and organisatio...

Duration and determinants of hospice-based sp...

Article indépendant | ALLSOP, Matthew J. | PALLIATIVE MEDICINE | n°8 | vol.32

BACKGROUND: Understanding service provision for patients with advanced disease is a research priority, with a need to identify barriers that limit widespread integration of palliative care. AIM: To identify patient and organisatio...

De la même série

Posttraumatic growth in palliative care setti...

Article indépendant | AUSTIN, Philip D. | PALLIATIVE MEDICINE | n°2 | vol.38

BACKGROUND: Posttraumatic growth refers to positive psychological change following trauma. However, there is a need to better understand the experience of posttraumatic growth in the palliative care setting as well as the availabi...

Long-term bereavement outcomes in family memb...

Article indépendant | LAPENSKIE, Julie | PALLIATIVE MEDICINE | n°2 | vol.38

Background: Severe grief is highly distressing and prevalent up to 1 year post-death among people bereaved during the first wave of COVID-19, but no study has assessed changes in grief severity beyond this timeframe. Aim: Understa...

Understanding the extent to which PROMs and P...

Article indépendant | HOWARD, Faith D. | PALLIATIVE MEDICINE | n°2 | vol.38

BACKGROUND: Older people with severe frailty are nearing the end of life but their needs are often unknown and unmet. Systematic ways to capture and measure the needs of this group are required. Patient reported Outcome Measures (...

The perspectives of people with dementia and ...

Article indépendant | MONNET, Fanny | PALLIATIVE MEDICINE | n°2 | vol.38

BACKGROUND: Advance care planning has been defined in an international consensus paper, supported by the European Association for Palliative Care. There are concerns that this definition may not apply to dementia. Moreover, it is ...

Revised European Association for Palliative C...

Article indépendant | SURGES, Séverine M. | PALLIATIVE MEDICINE | n°2 | vol.38

BACKGROUND: The European Association for Palliative Care (EAPC) acknowledges palliative sedation as an important, broadly accepted intervention for patients with life-limiting disease experiencing refractory symptoms. The EAPC the...

Chargement des enrichissements...